CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Update

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totaling 1,167 shares, a growth of 332.2% from the November 30th total of 270 shares. Based on an average daily trading volume, of 27,709 shares, the short-interest ratio is presently 0.0 days. Based on an average daily trading volume, of 27,709 shares, the short-interest ratio is presently 0.0 days.

CSPC Pharmaceutical Group Stock Performance

CSPCY stock opened at C$4.49 on Friday. The firm’s 50-day moving average is C$4.01 and its two-hundred day moving average is C$4.52. CSPC Pharmaceutical Group has a 52 week low of C$2.15 and a 52 week high of C$5.83.

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.